王燕, 宋琦 . 磁共振全身弥散加权成像在淋巴瘤临床诊疗方面的应用价值及研究进展[J]. 诊断学理论与实践, 2019 , 18(06) : 692 -697 . DOI: 10.16150/j.1671-2870.2019.06.018
| [1] | Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019[J]. CA Cancer J Clin, 2019, 69(1):7-34. |
| [2] | 陈万青, 孙可欣, 郑荣寿, 等. 2014年中国分地区恶性肿瘤发病和死亡分析[J]. 中国肿瘤, 2018, 27(1):1-14. |
| [3] | Cheson BD, Fisher RI, Barrington SF, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification[J]. J Clin Oncol, 2014, 32(27):3059-3068. |
| [4] | Takahara T, Imai Y, Yamashita T, et al. Diffusion weighted whole body imaging with background body signal suppression(DWIBS): technical improvement using free breathing, STIR and high resolution 3D display[J]. Radiat Med, 2004, 22(4):275-282. |
| [5] | Sasamori H, Uno K, Wu J. Usefulness of both PET/CT with 18F-FDG and whole-body diffusion-weighted imaging in cancer screening: a preliminary report[J]. Ann Nucl Med, 2019, 33(2):78-85. |
| [6] | Stecco A, Trisoglio A, Soligo E, et al. Whole-Body MRI with diffusion-weighted imaging in bone metastases: A narrative review[J]. Diagnostics(Basel), 2018, 8(3),pii:E45. |
| [7] | 王攀峰, 李永超, 徐杨, 等. 全身弥散加权成像(WB-DWI)在初诊多发性骨髓瘤患者中的诊断和监测作用[J]. 中华血液学杂志, 2017, 38(2):129-133. |
| [8] | Gong J, Cao W, Zhang Z, et al. Diagnostic efficacy of whole-body diffusion-weighted imaging in the detection of tumour recurrence and metastasis by comparison with 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography or computed tomography in patients with gastrointestinal cancer[J]. Gastroenterol Rep (Oxf), 2015, 3(2):128-135. |
| [9] | Bae YJ, Choi BS, Jeong HK, et al. Diffusion-weighted imaging of the head and neck: influence of fat-suppression technique and multishot 2D navigated interleaved acquisitions[J]. Am J Neuroradiol, 2018, 39(1):145-150. |
| [10] | Zhang H, Xue H, Alto S, et al. Integrated shimming improves lesion detection in whole-body diffusion-weighted examinations of patients with plasma disorder at 3 T[J]. Invest Radiol, 2016, 51(5):297-305. |
| [11] | Sotiropoulos SN, Moeller S, Jbabdi S, et al. Effects of image reconstruction on fiber orientation mapping from multichannel diffusion MRI: reducing the noise floor using SENSE[J]. Magn Reson Med, 2013, 70(6):1682-1689. |
| [12] | Reischauer C, Froehlich JM, Pless M, et al. Early treatment response in non-small cell lung cancer patients usi-ng diffusion-weighted imaging and functional diffusion maps--a feasibility study[J]. PLoS One, 2014, 9(10):e108052. |
| [13] | Reischauer C, Froehlich JM, Koh DM, et al. Bone metastases from prostate cancer: assessing treatment response by using diffusion-weighted imaging and functional diffusion maps--initial observations[J]. Radiology, 2010, 257(2):523-531. |
| [14] | Lin C, Luciani A, Itti E, et al. Whole-body diffusion-weighted magnetic resonance imaging with apparent diffusion coefficient mapping for staging patients with diffuse large B-cell lymphoma[J]. Eur Radiol, 2010, 20(8):2027-2038. |
| [15] | Balbo-Mussetto A, Cirillo S, Bruna R, et al. Whole-body MRI with diffusion-weighted imaging: a valuable alternative to contrast-enhanced CT for initial staging of aggressive lymphoma[J]. Clin Radiol, 2016, 71(3):271-279. |
| [16] | Serifoglu I, Oz II, Damar M, et al. Diffusion-weighted imaging in the head and neck region: usefulness of apparent diffusion coefficient values for characterization of lesions[J]. Diagn Interv Radiol, 2015, 21(3):208-214. |
| [17] | 李莉, 强永乾, 任转琴, 等. 全身弥散加权成像在全身淋巴结病变中的应用价值[J]. 实用放射学杂志, 2013, 29(4):631-634. |
| [18] | Mosavi F, Wassberg C, Selling J, et al. Whole-body diffusion-weighted MRI and(18)F-FDG PET/CT can discriminate between different lymphoma subtypes[J]. Clin Radiol, 2015, 70(11):1229-1236. |
| [19] | Wu X, Pertovaara H, Dastidar P, et al. ADC measurements in diffuse large B-cell lymphoma and follicular lymphoma: a DWI and cellularity study[J]. Eur J Radiol, 2013, 82(4):e158-e164. |
| [20] | Saboo SS, Krajewski KM, O'Regan KN, et al. Spleen in haematological malignancies: spectrum of imaging fin-dings[J]. Br J Radiol, 2012, 85(1009):81-92. |
| [21] | Littooij AS, Kwee TC, Barber I, et al. Accuracy of whole-body MRI in the assessment of splenic involvement in lymphoma[J]. Acta Radiol, 2016, 57(2):142-151. |
| [22] | Salmon JS, Thompson MA, Arildsen RC, et al. Non-Hodgkin's lymphoma involving the liver: clinical and therapeutic considerations[J]. Clin Lymphoma Myeloma, 2006, 6(4):273-280. |
| [23] | Haradome H, Grazioli L, Morone M, et al. T2-weighted and diffusion-weighted MRI for discriminating benign from malignant focal liver lesions: diagnostic abilities of single versus combined interpretations[J]. J Magn Reson Imaging, 2012, 35(6):1388-1396. |
| [24] | Colagrande S, Calistri L, Grazzini G, et al. MRI features of primary hepatic lymphoma[J]. Abdom Radiol (NY), 2018, 43(9):2277-2287. |
| [25] | Stecco A, Buemi F, Quagliozzi M, et al. Staging of primary abdominal lymphomas: Comparison of whole-body MRI with diffusion-weighted imaging and (18)F-FDG-PET/CT[J]. Gastroenterol Res Pract, 2015, 2015:104794. |
| [26] | Lin X, Lee M, Buck O, et al. Diagnostic Accuracy of T1-weighted dynamic contrast-enhanced-MRI and DWI-ADC for differentiation of glioblastoma and primary CNS lymphoma[J]. AJNR Am J Neuroradiol, 2017, 38(3):485-491. |
| [27] | Lister TA, Crowther D, Sutcliffe SB, et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting[J]. J Clin Oncol, 1989, 7(11):1630-1636. |
| [28] | Lin C, Itti E, Luciani A, et al. Whole-body diffusion-weighted imaging with apparent diffusion coefficient mapping for treatment response assessment in patients with diffuse large B-cell lymphoma: pilot study[J]. Invest Radiol, 2011, 46(5):341-349. |
| [29] | Littooij AS, Kwee TC, Barber I, et al. Whole-body MRI for initial staging of paediatric lymphoma: prospective comparison to an FDG-PET/CT-based reference standard[J]. Eur Radiol, 2014, 24(5):1153-1165. |
| [30] | de Paepe K, Bevernage C, De Keyzer F, et al. Whole-body diffusion-weighted magnetic resonance imaging at 3 Tesla for early assessment of treatment response in non-Hodgkin lymphoma: a pilot study[J]. Cancer Imaging, 2013, 13:53-62. |
| [31] | Albano D, Patti C, Matranga D, et al. Whole-body diffusion-weighted MR and FDG-PET/CT in Hodgkin Lymphoma: Predictive role before treatment and early assessment after two courses of ABVD[J]. Eur J Radiol, 2018, 103:90-98. |
| [32] | Hatakenaka M, Nakamura K, Yabuuchi H, et al. Pretreatment apparent diffusion coefficient of the primary lesion correlates with local failure in head-and-neck cancer treated with chemoradiotherapy or radiotherapy[J]. Int J Radiat Oncol Biol Phys, 2011, 81(2):339-345. |
| [33] | Schmeel FC, Simon B, Luetkens JA, et al. Prognostic value of pretreatment diffusion-weighted magnetic resonance imaging for outcome prediction of colorectal cancer liver metastases undergoing 90Y-microsphere radioembolization[J]. J Cancer Res Clin Oncol, 2017, 143(8):1531-1541. |
| [34] | Nael K, Bauer AH, Hormigo A, et al. Multiparametric MRI for differentiation of radiation necrosis from recurrent tumor in patients with treated glioblastoma[J]. Am J Roentgenol, 2018, 210(1):18-23. |
| [35] | Nural MS, Danaci M, Soyucok A, et al. Efficiency of apparent diffusion coefficients in differentiation of colorectal tumor recurrences and posttherapeutical soft-tissue changes[J]. Eur J Radiol, 2013, 82(10):1702-1709. |
| [36] | Littooij AS, Kwee TC, de Keizer B, et al. Whole-body MRI-DWI for assessment of residual disease after completion of therapy in lymphoma: A prospective multicenter study[J]. J Magn Reson Imaging, 2015, 42(6):1646-1655. |
| [37] | Sun M, Cheng J, Zhang Y, et al. Application of DWIBS in malignant lymphoma: correlation between ADC values and Ki-67 index[J]. Eur Radiol, 2018, 28(4):1701-1708. |
| [38] | 徐贤, 马林, 张爱莲, 等. 全身磁共振弥散加权成像对淋巴瘤的增殖活性、恶性程度和预后的评估[J]. 功能与分子医学影像学杂志(电子版), 2012, 1(1):14-18. |
/
| 〈 |
|
〉 |
